Laurus Labs’ investment in KRKA Pharma will be completed by March 31, 2025, through a cash subscription to 83.3 million equity shares of KRKA Pharma at ₹10 per share. Shares of Laurus Labs Ltd ended at ₹580, up by ₹13.45, or 2.37%, on the BSE.
Share it
